Company Profile
Year Established :
2002
Total Assets(USD) :
Choose not to disclose
Total Number of Staff :
300 to 349
Other Competitive Advantages :
innovation and ingenuity
flexibility and resilience
team-playing
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
Choose not to disclose
Main Sales Markets :
Central/South America,Asia
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Custom Manufacturing
Product Range :
5-methyluridine β-thymidine cytosine cytidine adenine
hyoxanthine acetamide tetraacetylribose sodium methoxide OTBN BRO-OTBN TTBB
Zhejiang Xianfeng Technologies Co., Ltd. is a specialized manufacturer of APIs and pharmaceutical intermeidates, founded in 2002 and located in Yongquan, Linhai, Zhejiang. Zhejiang xianfeng Technologies Co., Ltd. covers land area of more than 80,000 square meters and has got ISO 9001:2000 certification in 2004. Annual sales turnover in 2009 exceeded RMB 160million. Main products: Sartan´s API series include Losartan potassium, valsartan, Irbesartan; sartan´s intermediates include OTBN, BRO-OTBN, Anti-virus Drug´s intermediates include 5-methyl uridine, β-thymidine, cytosine, cytidine, Inosine, Adenine, Hyoxanthine, and Tetraacetylribose, sodium Mehoxide (liquid&solide)etc.
Nine years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
